Published in
Wiley Open Access, ESC Heart Failure, 4(8), p. 2580-2590, 2021
DOI: 10.1002/ehf2.13406
Links
Tools
Design and rationale of the EMPA‐VISION trial: investigating the metabolic effects of empagliflozin in patients with heart failure
Journal article published in 2021 by
Moritz J. Hundertmark,
Olorunsola F. Agbaje,
Ruth Coleman 
,
Jyothis T. George,
Rolf Grempler,
Rury R. Holman,
Hanan Lamlum,
Jisoo Lee,
Joanne E. Milton,
Heiko G. Niessen,
Oliver Rider,
Christopher T. Rodgers,
Ladislav Valkovič,
Eleanor Wicks,
Masliza Mahmod
and other authors.
,
Jyothis T. George,
Rolf Grempler,
Rury R. Holman,
Hanan Lamlum,
Jisoo Lee,
Joanne E. Milton,
Heiko G. Niessen,
Oliver Rider,
Christopher T. Rodgers,
Ladislav Valkovič,
Eleanor Wicks,
Masliza Mahmod
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Data provided by 